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Protein turnover critically influences many biological
functions, yet methods have been lacking to assess
this parameter in vivo. Here, we demonstrate how
chemical labeling of SNAP-tag fusion proteins can
be exploited tomeasure the half-life of resident intra-
cellular and extracellular proteins in living mice. First,
we demonstrate that SNAP-tag substrates have
wide bioavailability in mice and can be used for the
specific in vivo labeling of SNAP-tag fusion proteins.
We then apply near-infraredprobes toperformnonin-
vasive imaging of in vivo-labeled tumors. Finally, we
use SNAP-mediated chemical pulse-chase labeling
to perform measurement of the in vivo half-life of
different extra- and intracellular proteins. These
results open broad perspectives for studying protein
function in living animals.
INTRODUCTION
The stability and turnover of proteins in live cells is a carefully
controlled parameter that affects numerous biological functions,
which cell cycle, transcriptional control, or DNA damage res-
ponse are just a few examples of (Hershko and Ciechanover,
1998, Lakin and Jackson, 1999). Additionally, half-life of specific
proteins is altered in pathological situations such as viral infec-
tions (Mangasarian et al., 1997), neurodegenerative disorders
(Shin et al., 2011), or cancer (Hershko and Ciechanover, 1998).
A better understanding of degradation rates of specific proteins
in different conditions would facilitate drug development for
various human diseases (Bedford et al., 2011).
Traditionally, metabolic pulse-chase with isotopically labeled
amino acids has been used for decades to monitor the stability
of specific proteins in tissue culture (Dickson and Mendenhall,
2004), and a method of global profiling has recently been
described that allows the scale-up of such analyses to thou-
sands of proteins at a time (Yen et al., 2008). Isotopically labeled
amino acids have recently been used to measure protein turn-
over in vivo by mass spectrometry, and this technique was
applied to determine the synthesis and degradation rates of
b-amyloid in human patients of Alzheimer’sdisease (Bateman
et al., 2006; Mawuenyega et al., 2010). While an exciting devel-
opment, this approach has a number of limitations. First, the infu-Chemistry & Biology 18,sion of an isotopically labeled amino acid and its subsequent
washout is much slower in vivo than in tissue culture. The result-
ing lower temporal resolution restricts the use of the approach to
the study of proteins characterized by rather long half-lives.
Furthermore, pulse-chase labeling in vivo or in vitro does not
permit to distinguish between proteins present in different
cellular compartments, such as the plasma membrane and the
secretory pathway. The latter point is of critical importance
when the stability of membrane proteins is investigated. In light
of the importance of protein turnover in biological processes
(Ciechanover, 2005; Hershko and Ciechanover, 1998), it can
thus be concluded that there is an urgent need for alternative
and complementary approaches to measure this parameter
in vivo.
A powerful approach to characterize the properties of a protein
of interest is based on its expression as a fusion protein with an
appropriate tag. Fluorescent proteins (FPs) have been the most
widely exploited tags for studies of localization and function of
their fusion partners (Giepmans et al., 2006). Recently, photo-
activated variants of FPs have been generated that permit
monitoring protein turnover in cell culture (Fuchs et al., 2010).
However, the necessary photo-activation cannot easily be per-
formed in the depth of a living animal. As an alternative, various
chemical labeling techniques have been developed (Fernandez-
Suarez and Ting, 2008; Marks and Nolan, 2006). Chemical
labeling has been shown to be a versatile approach for studying
a range of protein properties, including protein stability, activity,
trafficking, and interactions with other biomolecules (Fernandez-
Suarez and Ting, 2008; Marks and Nolan, 2006; Tsukiji et al.,
2009). Chemical labeling provides a choice of probes each
tailored for a specific application. For example, synthetic fluoro-
phores are available that are ideally suited for either character-
izing protein-protein interactions by Fo¨rster resonance energy
transfer measurements or for noninvasive imaging in living
animals (Maurel et al., 2008; Tannous et al., 2006). Additionally,
chemical labeling permits the labeling of proteins at selected
time points to differentiate between different generations of
a given protein (so-called pulse-chase labeling experiments;
Gaietta et al., 2002). This has been exploited to measure the
half-life of fusion proteins in cell culture and to visualize the
formation of biological structures (Gaietta et al., 2002; Jansen
et al., 2007; Vivero-Pol et al., 2005) and potentially might also
permit to study protein half-life in living animals.
One self-labeling tag that appears particularly well suited
for measuring in vivo protein half-life through chemical
labeling is the so-called SNAP-tag. SNAP-tag is a mutant of
human O6-alkylguanine-DNA alkyltransferase (AGT) that permits805–815, June 24, 2011 ª2011 Elsevier Ltd All rights reserved 805
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Figure 1. In Vivo Chemical Labeling of SNAP-GPI Transgenic Mice
(A) Phenotyping of SNAP-GPI transgenicmice on primary ear fibroblasts. In vitro cultured primary fibroblasts from SNAP-GPI (left) orWT (right) mice were labeled
with BG-547 and imaged under a wide-field fluorescencemicroscope. Top and bottom represent fluorescent and phase contrast images, respectively. Scale bar
is 100 mm.
(B) Assessing in vivo protein labeling with BG-782 of SNAP-GPI transgenic mice by SDS-PAGE of protein extracts and subsequent in-gel fluorescence scanning.
Organs were harvested 4 and 8 hr after injection of BG-782. Wild-type mice injected with BG-782 or noninjected mice were used as controls. Left: fluorescent
in-gel scan. Middle: HA-specific western blotting; in the skin and spleen of WTmice, a background band, that could come from cross-reactivity of the secondary
anti-mouse IgG antibodywith endogenous immunoglobulins present in the tissues, is present almost at the same apparent molecular weight as SNAP-GPI. Right:
tubulin-specific western blotting as protein loading control.
(C) SNAP-GPI is highly expressed in the brain but not in the liver. Indicated mice were injected with BG-682 and organs were harvested after 4 hr. Tissues were
labeled with BG-782 and protein extracts were resolved by SDS-PAGE.
See also Figure S1 and Table S1.
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SNAP-Tag Labeling in Living Micespecific and irreversible labeling with O6-benzylguanine (BG)
derivatives carrying molecular probes (Gronemeyer et al.,
2006; Keppler et al., 2003; Keppler et al., 2004). SNAP-tag has
previously been used in cell culture for the pulse-chase labeling
of intra- and extracellular proteins (Jansen et al., 2007; Keppler
et al., 2004). It has also been demonstrated not to affect the func-
tion of a large number of fusion proteins (Hein et al., 2010; Jansen
et al., 2007; Keppler et al., 2003, 2004; Klein et al., 2011; Maurel
et al., 2008). BGwas developed in the 1980s as a potent inhibitor
of human AGT upregulated in various cancers and is used at very
high doses in combination with chemotherapy in clinical trials for
treatment of human tumors (Quinn et al., 2009). Pharmacology,
metabolism and side effects of BG treatment have been exten-
sively studied and described in mice, rats, and humans (Dolan
et al., 1994; Sabharwal and Middleton, 2006). In these studies,
no major side effects have been observed after in vivo adminis-
tration of BG. Together, these properties make SNAP-tag an
attractive candidate for measuring in vivo protein stability in
living animals.
In the present study, we demonstrate that SNAP-tag can be
used for in vivo imaging of fusion proteins in living mice and
that the labeling is specific and efficient in most mouse organs.806 Chemistry & Biology 18, 805–815, June 24, 2011 ª2011 ElsevierMoreover, we show that SNAP-tag can be used for in vivo
pulse-chase experiments followed by an ex vivo protein analysis
and determination of in vivo protein half-life in living organisms.
RESULTS
In Vivo Labeling of SNAP-Tag in Transgenic Mice
We first tested the efficiency of SNAP-tag labeling in living
animals. We generated transgenic mice by perivitelline injection
into a fertilized mouse oocyte of a lentivector expressing SNAP-
tag fused to a GPI anchor (SNAP-GPI) from the ubiquitous CAG
or ubiquitin C promoters. To verify that the transgene was cor-
rectly expressed on the cell surface, we phenotyped the mice
by harvesting primary ear fibroblasts and labeling them in cell
culture with BG-547 (further information concerning BG deriva-
tives is provided in Table S1, available online). A cell surface-
specific signal was detected in cells harvested from SNAP-GPI
mice but not in the wild-type controls (Figure 1A). We then
injected a series of BG derivatives into these animals and
assessed the specific labeling of SNAP-GPI in various organs
by SDS-PAGE of protein extracts followed by in-gel fluores-
cence scanning 4 and 8 hr after the probe injection. As illustratedLtd All rights reserved
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Figure 2. In Vivo Labeling and Noninvasive Imaging of SNAP-GPI-
Expressing Tumors
(A) In vivo imaging of a nudemouse bearing TSA SNAP-GPI (left) andWT (right)
tumors 24 hr after an intravenous injection of BG-782.
(B) In vivo labeling of tumor-bearing mice with different doses of BG deriva-
tives. Top: Three nude mice bearing SNAP-GPI expressing tumor (left flank) or
WT tumor (right flank) were injected with indicated doses of BG-782 and
imaging was performed at the indicated time points. Red arrows indicate the
SNAP-GPI tumor; black arrows indicate the injection site; black and white
arrowheads indicate probe accumulated in the intestines and in kidneys,
respectively. The brightness and contrast were optimized in later time points in
order to visualize the signal. Bottom: Graph represents the ratio of signal from
SNAP-GPI (black lines) and WT (gray lines) tumors to background of mouse
tissues from experiment depicted in B for the indicated doses of BG-782.
Chemistry & Biology
SNAP-Tag Labeling in Living Mice
Chemistry & Biology 18,for the BG-782 probe, specific labeling occurred in most of the
organs examined (Figure 1B; Figure S1). The fluorescent signal
was strong in muscles, heart, kidney, spleen, skin, lungs, and
testis, while it was weaker in the liver, and hardly detectable in
the brain. Similar results were obtained with other probes tested
(Table S1; data not shown). SNAP-GPI expression in the various
organs was analyzed in parallel by western blotting with an anti-
body against the HA-tag carried by the SNAP-tag fusion protein
(Figure 1B). Strong expression was confirmed in most organs
including the brain, but not in the liver. This indicated that the
lack of live labeling in the liver stemmed from the very low
expression of SNAP-GPI in this organ, while for its counterpart
in the brain, it most likely resulted from a failure of the label to
cross the blood-brain barrier. This was confirmed by harvesting
organs from mice injected with BG-682, labeling them in vitro
with BG-782 and analyzing the samples by SDS-PAGE (Fig-
ure 1C). BG itself is known to diffuse through the blood-brain
barrier and inhibit the endogenous O6-alkylguanine-DNA alkyl-
transferase (AGT) in mice (Kreklau et al., 2001). However, the
probes used here carry significant modifications compared
with the parental molecule, explaining their altered bioavail-
ability. These results demonstrate that BG derivatives have
wide bioavailability, permitting specific labeling of SNAP-fusion
proteins in different mouse tissues.
Noninvasive Imaging of SNAP-GPI-Expressing Tumors
in Living Mice
To further evaluate properties of the probes available for
SNAP-tag labeling, we asked if in vivo-labeled SNAP-tag can
be detected noninvasively by imaging techniques. Nude mice
were implanted with murine breast carcinoma cells either engi-
neered to express SNAP-GPI or left unmodified as a negative
control. When the tumor reached 0.5 cm3 in size, the infrared
fluorescent probe BG-782 was injected intravenously and
imaging was performed 24 hr later. As illustrated in Figure 2A,
a fluorescent signal was detected from SNAP-GPI-expressing
but not fromWT control tumors.We then determined the settings
that gave the best signal-to-noise ratio. Mice bearing SNAP-GPI
tumors were injected with 4, 10, or 15 nmol of BG-782 permouse
and imaged at several time points (Figure 2B). A strong signal
was detected in SNAP-expressing tumor tissue at each time
point for all of doses tested. Early after probe injection, unspe-
cific signal from unbound probe was present in the gut and liver,
while at later time points, only an unspecific signal resulting from
the probewas detected in kidneys. However, after themajority of805–815, June 24, 2011 ª2011 Elsevier Ltd All rights reserved 807
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Figure 3. SNAP-CD4 Is Functional
(A) Upper panel: scheme of the experimental procedure. Jurkat cells expressing indicated SNAP fusion proteins first labeled with BG-547 were then blocked with
BG and incubated with indicated doses of phorbol 12-myristate 13-acetate (PMA) at 37C for 20 min. Middle and lower panel: Graphs show the percentage of
BG-547 positive cells in the indicated samples trypsinized (middle) or not (lower), as assessed by flow cytometry. In SNAP-CD4* the extracellular domain of CD4 is
replaced by SNAP. SNAP-CD4*LL- > AA is a double point mutant of CD4 (Leu413,414- > Ala413,414) resistant to PMA-induced endocytosis (Aiken et al., 1994). Error
bars represent standard deviation.
(B) SNAP-CD4 but not SNAP-GPI recruits Lck. Protein extracts from Jurkat cells expressing indicated SNAP fusion proteins were incubated with agarose beads
displaying BG. The immobilized proteins were then eluted and blotted with Lck- and SNAP-specific antibodies. TI-total input, SN-supernatant, PD-pull-down
fraction.
(C) SNAP-CD4 can serve as a receptor for HIV-1. Flow cytometry analysis of 293T cells transfected with plasmids expressing SNAP-GPI, SNAP-CD4, or wt
human CD4 and infected with a GFP-encoding lentiviral vector pseudotyped with lymphotropic HIV-1 envelope glycoprotein. Dot plots showGFP and SNAP-547
(red probe) expression 48 hr after labeling with BG-547.
See also Figure S2.
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SNAP-Tag Labeling in Living Miceunbound probe was excreted from the system, strong signal
above background was detected only in the SNAP-expressing
tumor. Notably, after injection of 4 nmol of BG-782 the back-
ground from unbound probe was significantly lower than in-
duced by higher doses, whereas SNAP-GPI tumor labeling
was very efficient at all doses (Figure 2B). Thus, the lowest doses
of BG-782 gave the best result, comparable to data previously
obtained with infrared fluorescent proteins (Shu et al., 2009),
and the best time for imaging was at 24 hr (Figure 2B). These
results indicate that SNAP-tag fusion proteins in vivo-labeled
with low doses of BG-782 can be noninvasively detected by
means of fluorescence imaging.
Assessing the Possible Impact of SNAP-Tag on Fusion
Protein Functionality and Stability In Vitro
We generated a SNAP-CD4 fusion protein (SNAP-CD4), in which
the tag was placed downstream of the ER-targeting signal
peptide of human CD4, and stably expressed this protein in
human lymphoid Jurkat cells. We first tested the functionality of808 Chemistry & Biology 18, 805–815, June 24, 2011 ª2011 Elsevierthis molecule to ensure that SNAP-tag did not interfere with
CD4 function. We performed an endocytosis assay in which cells
expressing SNAP-CD4 were labeled with BG-547, washed and
treated with various concentrations of phorbol-12-myristate-13-
acetate (PMA) known to induce CD4 internalization (Pelchen-
Matthews et al., 1991, 1993; Ruegg et al., 1992). Half of each
sample was then trypsinized to digest extracellular proteins,
including SNAP-CD4-782, and cells were analyzed by flow
cytometry. In this assay, fluorescent signal observed after
trypsynization results only from endocytosed SNAP-CD4-782.
As shown inFigure3A,wecouldverify thatSNAP-CD4underwent
endocytosis upon cell activation with phorbol esters. Further-
more, using BG-coated magnetic beads, we could demonstrate
that, as previously shown for the parental molecule CD4 (Aiken
etal.,1994),SNAP-CD4 interactedwith theLckkinase (Figure3B).
Moreover, similarly to CD4 (Dalgleish et al., 1984), the SNAP-CD4
derivative served as an efficient receptor for HIV1 entry, as its
expression was sufficient for infection of HEK293T cells with a
lymphotropic, GFP-encoding lentiviral vector (Figure 3C).Ltd All rights reserved
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Figure 4. In Vitro and In Vivo Pulse-Chase of Extracellular SNAP-
Fusion Proteins
Cells (n = 3–6 for SNAP-CD4; n = 7 for SNAP-GPI; average of two independent
experiments) or mice (n = 4) bearing SNAP-tag expressing Jurkat tumors were
pulse-labeled with BG-782, blocked with BG and samples were harvested at
different time points.
(A) Quantification of fluorescent signal by SDS-PAGE gels of pulse-chase
experiments of SNAP-CD4 (top) and SNAP-GPI (bottom) expressing cells.
Data are fitted to a single exponential decay equation. Graphs showSNAP-782
signal at different time points after blocking as percentage of time 0 hr signal.
(B) SNAP-CD4 pool in the endosome. The graph shows quantification of
fluorescent signal from protein extracts resolved by SDS-PAGE at different
time points after blocking as a percentage of total fluorescent signal from cells
without trypsinization.
See also Figure S3. Error bars represent SEM.
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SNAP-Tag Labeling in Living MiceAfter having determined that fusion with SNAP-tag does not
perturb CD4 function, we determined the half-lives of SNAP-
CD4 and SNAP-GPI in cultured Jurkat T cells. Jurkat T cells
expressing these fusion proteins were labeled with 5 mM of
cell-impermeable BG-782 and treated with 500 mM BG to block
remaining unlabeled SNAP-tag. The cells were then harvested
at sequential time points and the amount of labeled SNAP-tag
was determined by in-gel fluorescence scanning of proteins
resolved by SDS-PAGE (Figure 4A; Figure S3A). Comparable
to previously published data for the rate of turnover of CD4
(Aiken et al., 1994; Pelchen-Matthews et al., 1991, 1993; Ruegg
et al., 1992), the half-life of cell surface-labeled SNAP-CD4 was
5.2 hr, while that of SNAP-GPI was 3.8 hr. SNAP-CD4 was
rapidly endocytosed and degraded upon PMA treatment, which
reduced its postcell surface migration half-life to about 48 min
(Figures 3A and 4A; Figure S3A) and increased its intracellular
fraction from 10% to 80% (Figure 4B). These results are in agree-
ment with previous studies focused on the effect of phorbol
esters on rate of turnover of wild-type CD4 (Pelchen-Matthews
et al., 1991, 1993; Ruegg et al., 1992), where PMA treatment of
a lymphoid cell line SupT1 resulted in a decrease of post-cell
surfacemigration half-life of CD4 to20min. In the current study
CD4 half-life is determined in yet another cell line, with use of
lower doses of PMA (10 ng/ml compared to 100 ng/ml in Pel-
chen-Matthews et al., 1993). We believe that the slight differ-
ences in post-cell surface migration half-life between the two
studies are due to the experimental conditions. In summary,
these experiments thus established that SNAP-CD4 retains the
function of wild-type CD4 and that its half-live can be readily
determined through pulse-chase labeling in vitro.
As a further control, we verified that labeling of SNAP-tag did
not lead to its ubiquitination and degradation in proteasome, as
has been reported for parental AGT (Daniels et al., 2000; Xu-
Welliver and Pegg, 2002). For this, wemeasured the in vitro ubiq-
uitylation of SNAP-tag before and after its labeling (Figure S2).
The results demonstrated that labeling triggered only minimal
levels of ubiquitylation, with the modified protein representing
at most 2.5% of its nonubiquitylated counterpart. These results
are also in agreement with previously published data where
pulse-chase labeling of SNAP-CENP-Awas applied in living cells
to follow the labeled fusion protein for more than two cell divi-
sions and no degradation could be detected (Jansen et al.,
2007).
In Vivo Determination of the Half-Life of a Cell Surface
Protein
The subcutaneous implantation of the modified Jurkat cells in
immunodeficient mice led to formation of tumors that were easily
detectable by noninvasive fluorescence imaging after in vivo
labeling of the surface fraction of SNAP-CD4 molecules with
the cell-impermeable near-infrared probe BG-782 (Figure 5A).
To demonstrate the feasibility of pulse-chase labeling experi-
ments in vivo, we injected BG-782 (the pulse) in Rag2-gchain
KO immunodeficient mice bearing subcutaneous Jurkat-derived
tumors expressing SNAP-CD4, followed by a high dose of BG
(the chase) (Figure 5B). One hour after the in vivo injection of
BG, tumors were isolated and tissue homogenates incubated
with BG-fluorescein. BG-fluorescein displays nonoverlapping
excitation and emission spectra relative to BG-782 (Table S1),Chemistry & Biology 18,allowing a distinction of signals resulting from in vivo and in
vitro-labeling reactions. No labeling of SNAP-CD4 with fluores-
cein could be detected whereas a strong fluorescein labeling
was observed when the in vivo labeling steps were omitted (Fig-
ure 5B). These experiments demonstrate that chemical labeling
of SNAP-tag lends itself to pulse-chase experiments in living
animals and that both the pulse and the chase can be completed
in 1 hr at most.805–815, June 24, 2011 ª2011 Elsevier Ltd All rights reserved 809
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Figure 5. In Vivo Labeling of Mice Bearing SNAP-CD4-Expressing
Jurkat T Cell-Derived Tumors
(A) In vivo imaging of a Rag2gcKO mouse bearing SNAP-CD4 (left) and WT
(right) tumors 24 hr after an intravenous injection of BG-782 (200 pmol/g BW).
Hair was removed prior to imaging.
(B) In vivo blocking of SNAP-CD4with high-dose BG. Upper panels: scheme of
the experimental procedure. Rag2gcKO mice bearing SNAP-CD4-expressing
and control tumors were injected intravenously with 5 nmol/25 g BW of
BG-782 (blocked mouse) or vehicle alone (control mouse). The labeled protein
was chased with 500 nmol of BG per 25 g BW (blocked mouse). Tumor tissue
was in vitro labeled with 10 mM BG-fluorescein. Lower panel: protein extracts
were resolved by SDS-PAGE and examined by in-gel fluorescence scanning.
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SNAP-Tag Labeling in Living MiceRag2-gchain KO-immunodeficient mice bearing subcuta-
neous Jurkat-derived tumors expressing either SNAP-CD4 or
SNAP-GPI were injected with BG-782 (pulse) and 1 hr later
with a high dose of BG (chase). Protein extracts prepared from
tumors harvested at sequential time points were then analyzed
by SDS-PAGE and in-gel fluorescence scanning (Figure 4A;
Figure S3B). Application of this chemical labeling technique al-
lowed us to measure in vivo half-lives of SNAP-CD4 and
SNAP-GPI, which were 3.7 and 4.1 hr, respectively. The acceler-810 Chemistry & Biology 18, 805–815, June 24, 2011 ª2011 Elsevierated turnover of SNAP-CD4 in living mice compared with cell
culture could reflect increased levels of cellular activation
in vivo, consistent with differences between the in vitro and
in vivo models further emphasizing the importance of studying
protein function in living organisms.
In Vivo Determination of the Half-Life of a Nuclear
Protein
In the previous experiments, labeling was facilitated by extracel-
lular expression of SNAP-tag fusion proteins. To test the gener-
ality of the in vivo pulse-chase labeling method, we then asked
whether it could be applied to intracellular proteins. We fused
SNAP-tag to murine KAP1 (Kru¨ppel associated box (KRAB)-
associated protein 1), an epigenetic master regulator (Sripathy
et al., 2006; Figure 6). The resulting SNAP-KAP1 fusion protein
was almost exclusively nuclear (Figure 6A), its expression was
comparable with that of endogenous KAP1 in mouse embryonic
fibroblasts (MEFs) (Figure 6B) and, similarly to its wild-type coun-
terpart, SNAP-KAP1 was functional in a reporter assay based on
tTR-KRAB (tetracycline repressor from Escherichia coli fused to
KRAB domain)-mediated repression of GFP transcription (Fig-
ure 6C). We then determined that the half-life of SNAP-KAP1 in
MEFs was 17.5 hr (Figure 7A; Figure S4A). In order to examine
this latter parameter in vivo, we transplanted hematopoietic
stem cells transduced ex vivo with a SNAP-KAP1 expressing
lentiviral vector into lethally irradiated mice. We then pulsed
the mice with the cell-permeable SNAP-tag substrate TMR-
Star, blocked the labeling reaction with a high dose of BG, har-
vested spleens at different time points, and processed the
samples through SDS-PAGE and in-gel fluorescence scanning
(Figure 7B; Figure S4B). As observed for the BG-782 tested in
transgenic and tumor bearingmice (Figures 1, 2, and 4), CP-TMR
also diffused to spleen for SNAP-tag labeling. Using this
approach, we determined that the in vivo half-life of SNAP-
KAP1 in the spleen was 11 hr. The expression levels of the
SNAP-KAP1 fusion protein observed in these experiments
were lower than that of its endogenous KAP1 counterpart in
the spleen and other organs (Figure S5; data not shown), demon-
strating that our approach permits the analysis of intracellular
SNAP-tag fusion proteins expressed at low concentrations.
DISCUSSION
Rate of protein turnover in live cells is an important and carefully
controlled parameter affecting many cellular functions. The
specific chemical labeling of fusion proteins with small fluores-
cent probes to measure protein half-life is a powerful alternative
to metabolic pulse-chase labeling with radioactive amino acids
but so far has only been applied in cell culture experiments. In
this study, we demonstrate for the first time how chemical
labeling of SNAP-tag fusion proteins can be utilized to measure
protein in vivo half-life in animals. Importantly, these experiments
describe a general method to characterize a previously inacces-
sible key property of proteins.
In vivo labeling of SNAP-GPI transgenic mice demonstrated
that BG derivatives have wide bioavailability and label SNAP
fusion proteins in most organs. The lack of labeling in the brain
could be explained by a lack of blood-brain barrier crossing by
BG derivatives, probably due to their increasedmolecular weightLtd All rights reserved
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(A) SNAP-KAP1 expression in mouse embryonic fibroblasts (MEFs). MEFs KO for KAP1 were transduced with a lentivector encoding for SNAP-KAP1. Cells were
labeled with 1 mM TMR-Star and washed prior to imaging. Scale bar is 100 mm.
(B) SNAP-KAP1 expression in MEFs is similar to that of endogenous KAP1 protein. Protein extracts from WT, KAP1 KO, and KAP1 KO MEFs transduced with
SNAP-KAP1 encoding lentivector were resolved by SDS-PAGE transferred on a nitrocellulose membrane and blotted with anti-KAP1 and anti-PCNA antibodies.
(C) SNAP-KAP1 is a potent gene repressor. Upper cartoons: schematic of the vector encoding for GFP and tTR-KRAB repressor under the control of a doxy-
cycline regulatable promoter used for KAP1 KO MEFs infection (left: in absence of doxycycline GFP is not transcribed; right: in presence of doxycycline GFP is
transcribed). Lower panels: flow cytometry dot plots showing GFP expression in the presence (+ dox) and absence (- dox) of doxycycline of infected cells
complemented with SNAP-KAP1 (top) or KAP1 alone (bottom).
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BG (Kreklau et al., 2001). Indeed, other charged fluorescent
probes have been shown to possess limited ability to penetrate
the blood-brain barrier, which can in some cases be overcome
by chemical modifications (Pham et al., 2005).Chemistry & Biology 18,Chemical labeling of SNAP-tagged proteins have several
advantages when compared with other available techniques.
First, it shows high versatility and allows for exploiting a wide
range of chemical moieties that can be utilized for labeling, in
particular, when compared with the use of autofluorescent805–815, June 24, 2011 ª2011 Elsevier Ltd All rights reserved 811
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Figure 7. Pulse-Chase of SNAP-KAP1 in Mouse Embryonic Fibroblasts and in Mouse Spleen
(A) Graph shows average of fluorescent signal from two (SNAP-KAP1; n = 3-6) or one (SNAP-KAP1 uponmitomycin C treatment; n = 3) independent pulse-chase
experiments.
(B) Graph shows the quantification of signal fromSDS-PAGEgels from the in vivo pulse-chase experiment in SNAP-KAP1 expressing spleens of (n = 3–6)mice per
time point. Signal at different time points is shown as percentage of time 0 hr signal. Data were fitted to a single exponential decay equation. Error bars represent
SEM.
See also Figures S4 and S5.
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rescent probes allow the noninvasive imaging of subcutaneous
tumors upon in vivo labeling. It appears feasible that the method
can be extended to probes endowed with different properties,
for example, probes suitable for magnetic resonance imaging
or positron emission tomography. However, our approach
currently does not allow tomeasure protein turnover by noninva-
sive imaging, due to relatively slow pharmacokinetic clearance of
the nonreacted probe. This limitation could potentially be over-
come by the design of fluorogenic BG derivatives that become
fluorescent only upon reaction with SNAP-tag. For example, flu-
orogenic substrates of matrix metalloproteinases have been
successfully used for the imaging of these proteins in mice
(Bremer et al., 2001).
A particularly attractive feature of chemical labeling over other
protein tagging techniques is the control over the labeling time
point. Additionally, it allows for use of different probes for labeling
at different time points. Such pulse-chase labeling experiments
are ideally suited for measuring protein half-life and to track
biological structure formation. Accordingly, we demonstrate
here that pulse-chase labeling of SNAP-fusion proteins repre-
sents a general method for the determination of in vivo protein
half-life. Importantly, the described method can be applied to
any protein amenable to expression as a fusion partner, whether
cell-associated or secreted.
Our approach complements another approach to measure
in vivo protein synthesis and clearance rates which was recently
applied to determine b-amyloid turnover rates in humans afflicted
with Alzheimer’s disease (Bateman et al., 2006; Mawuenyega
et al., 2010). This approach is based on injecting an isotopically
labeled amino acid (13C6-leucine) followed by sample collection,
immunoprecipitation of the protein of interest and high resolution
tandem mass spectrometry (MS) to identify isotope-labeled
species. The biggest conceptual advantage of this approach is
that it permits the analysis of endogenous proteins. Neverthe-
less, it also has certain limitations. First, the infusion of an isoto-
pically labeled amino acid and its subsequent washout is much
slower in vivo than a corresponding experiment in tissue culture.
To determine in vivo synthesis and clearance rates of b-amyloid,812 Chemistry & Biology 18, 805–815, June 24, 2011 ª2011 Elsevierthe authors performed a 9 hr continuous infusion of the isotope-
labeled amino acid in patients (Bateman et al., 2006). Upon with-
drawal of the isotope treatment, the plasma levels of 13C6-leucine
progressively decreased from 15% of total amino acid in plasma
to 1%within 7 hr. By comparison, the time required for SNAP-tag
in vivo labeling was 1 hr, whereas the chase with a high dose of
BG was also completed within 1 hr. This proved important for
thedetermination of the in vivo half-lives of proteinswith relatively
short half-lives (Figure 4). Additionally, isotope labeling does not
distinguish between proteins present in different cellular
compartments. In contrast, the use of BGderivativeswith varying
permeability permits to study the half-life of the extra- and
intracellular populations of SNAP-tag fusions separately. For
example, by using membrane impermeable probes the in vivo
half-life of the extra-cellular population of CD4 could be deter-
mined. Both methods rely on quantification of the amount of
isolated protein of interest at different time points and therefore
require the sacrifice of numerous animals when proteins are
investigated that cannot be isolated from body fluids.
In the cases studied here, SNAP-tag did not significantly affect
the stability of its fusion partners and labeling itself did not affect
this parameter either. In vivo measured protein half-lives were
thus primarily determined by the stability of the parental mole-
cules. It is impossible to predict and difficult to prove if a fusion
protein faithfully copies the relevant properties of the corre-
sponding wild-type protein (Johnsson and Johnsson, 2003).
Experience accumulated in tissue culture with SNAP-tag indi-
cates that it is no more problematic than any other commonly
used tags. We also demonstrate that SNAP-tag fusion partners
used in the current study retain the biological functions of their
parental molecule (Figures 3 and 6). Nevertheless, it is crucial
for the validity of our method that key protein functions such as
localization and degradation rates of the fusion protein are inves-
tigated in vitro and compared with wild-type protein prior to
proceeding with in vivo experiments.
In conclusion, our experiments show that chemical labeling of
proteins is a versatile and valuable approach to study protein
function in living animals. In particular, it permits the establish-
ment of a general method to measure in vivo protein-half life.Ltd All rights reserved
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the characterization of mammalian proteins in their natural
environment.
SIGNIFICANCE
Methods for measuring in vivo half-life of proteins are dearly
needed both to pursue fundamental investigations and to
develop and perform preclinical studies. Techniques based
on chemical labeling have critically contributed to studies
of protein function and stability in cell culture systems. Their
application to the conduct of experiments in living organ-
isms has not been extensive. Here, we demonstrate how
chemical labeling can be used not only for labeling specific
proteins in vivo and visualizing them by imaging methods,
but also for determining their half-life in living mice. For
this, we took advantage of SNAP-tag, a recently developed
labeling method based on an engineered mutant of human
O6-alkylguanine-DNA alkyltransferase. Keys to the success
of our approach are (1) the low toxicity of benzylguanine (BG)
derivatives used for labeling, allowing for high in vivo probe
concentrations; (2) the high specificity of the labeling of
SNAP-tag, making it amenable for in vivo protein labeling
in mice, (3) the fact that SNAP-tag is a relatively benign
protein tag which generally does not affect the function of
its fusion partner. By describing this new method for the
evaluation of protein stability in vivo, our work opens broad
perspectives for biological research.
EXPERIMENTAL PROCEDURES
Probes and Reagents
Benzylguanine derivatives and the SNAP-specific antibody were kindly
provided by Covalys Biosciences (Switzerland) and New England Biolabs
(US). Phorbol 12-myristate 13-acetate was obtained from Sigma-Aldrich
(Switzerland). Lck-specific antibody was from United Biomedical (US); Anti-
PCNA antibody was from EMD Biosciences (Germany); Anti-tubulin anti-
body was from Sigma-Aldrich (Switzerland), Anti-KAP1 antibody was from
PTG labs, Manchester (UK), Anti-HA-HRP 3F10 antibody was from Roche
(Switzerland).
Cell Culture, Vectors, and Transgenic Mice
Cells were cultured according to standard protocols as previously described
(Barde et al., 2009; Maurice et al., 2002). Lentiviral vectors and transgenic
mice were prepared according to standard protocols (Salmon and Trono,
2006; Lois et al., 2002). Details of plasmid sequences will be provided on
demand. For in vitro labeling, cells expressing SNAP-tag were incubated with
1–2 mM BG derivatives for 5–15 min at 37C and washed with cell culture
medium before fixation with 1% formaldehyde (Sigma-Aldrich, Switzerland)
in PBS for flow cytometry analysis or imaging. Formitomycin treatment, murine
embryonic fibroblasts were incubated with 2 mg/ml of mitomycin C (Sigma-
Aldrich) for 2.5 hr at 37C20hrbefore thebeginningof pulse-chaseexperiment.
In Vitro Pulse-Chase Experiments
Jurkat cells expressing SNAP fusion proteins were labeled for 15minwith 2 mM
BG-547 (for flow cytometry) or BG-782 (for SDS-PAGE), washed, blocked
with 500 mM BG and incubated with indicated doses of phorbol 12-myristate
13-acetate (PMA) at 37C for 20 min. After extensive washing, half of the
sample was trypsinized and cells were analyzed by flow cytometry or by
SDS-PAGE followed by in-gel fluorescence scanning. In SNAP-CD4* the entire
extracellular domain of CD4 is replaced by SNAP. SNAP-CD4*LL- > AA is
a double point mutant of CD4 (Leu413,414- > Ala413,414) resistant to PMA-
induced endocytosis (Aiken et al., 1994).Chemistry & Biology 18,MEFs expressing SNAP-KAP1 were labeled with 1 mM of TMR-Star for
10 min, washed, and blocked with 500 mM BG. Samples were harvested at
different time points for protein extraction and SDS-PAGE followed by fluores-
cence-in-gel scanning.
Lck Pull-Down Assay and Evaluation of SNAP-CD4 as a Receptor
for HIV-1
Protein extracts from Jurkat cells expressing the indicated SNAP fusion
proteins were incubated with agarose beads displaying BG (Covalys Biosci-
ences, Switzerland). After extensive washing, the immobilized proteins were
eluted, transferred on a nitrocellulose membrane and blotted with Lck- and
SNAP-specific antibodies. 293T cells were transfected with 1 mg of plasmids
expressing SNAP-GPI, SNAP-CD4, or wt human CD4. Twenty hours later,
the cells were infected with a GFP-encoding lentiviral vector pseudotyped
with lymphotropic HIV-1 envelope glycoprotein. After 48 hr, the cells were
labeled with 2 mM BG-547, fixed, and analyzed by flow cytometry.
SDS-PAGE and Western Blotting
For SDS-PAGE in-gel fluorescence scanning and western blot analysis,
protein extracts (20 mg for in vitro experiments or 100–150 mg for in vivo exper-
iments) were resolved by SDS-PAGE, scanned on a Typhoon TRIO Variable
Mode Imager (GE Healthcare, USA) or LI-COR Odyssey Imager (Germany)
and then stainedwith Coomassie brilliant blue or transferred on a nitrocellulose
membrane for western blotting with the indicated antibodies.
Mouse Tumor Models
Six-week-old female Crl:Nu(Ico)-Foxn1 nude (Charles Rivers, France) or
Rag2gcKO mice (Taconic, USA) were injected subcutaneously with 10
6 TSA
murine mammary carcinoma cells (kindly provided by Luigi Naldini) or 107
Jurkat T cells, respectively. Mice were examined daily and used for experiment
when the tumor growth was visible, 2 or 4–5 weeks after TSA and Jurkat cell
engraftment, respectively.
For in vivo imaging, at indicated time points after the indicated probe
injection, mice were anaesthetized by inhalation of isolfluorane and imaged
on LI-COR Odyssey Imager with use of the MousePOD accessory for in vivo
imaging. Hair was removed from back of Rag2gcKO mice prior to imaging.
Hematopoietic Stem Cell Transplant Model
Murine HSCs harvested by flow cytometry sorting from bone marrow of donor
CD45.1 males were transduced overnight with multiplicity of infection (MOI) of
250 of the RLL-hPGK-SNAP-HA-KAP1 vector and injected into lethally irradi-
ated recipient CD45.2 females (14,000 HSC per mouse, together with 500,000
accessory total bonemarrowcells).Micewere treatedwithantibiotic for3weeks
and examined daily. Blood chimerism was estimated 5 weeks after the graft by
stainingperipheral bloodmononuclear cellswith antibodies againstCD45.2 and
CD45.1 and performing flow cytometry analysis. Chimerism was 30%–50%.
Animalswere used for in vivopulse-chase 8–10weeks after theHSC transplant.
In Vivo Labeling and Pulse-Chase Experiments
Labeling of transgenic mice was performed by intravenous injection of
120–200 pmol/g body weight (BW) of the indicated probes. Mice bearing
SNAP-tag expressing Jurkat derived tumors were in vivo pulsed with 5 nmol
BG-782/25 g BW and the unlabeled protein was chased with a 100 times
higher dose of BG. Tumors were harvested at different time points after the
labeling, tissue was incubated with 10 mMof BG-fluorescein to check for unla-
beled SNAP (not shown), and the protein extracts were resolved by
SDS-PAGE and analyzed by in-gel fluorescence scanning.
Mice, engraftedwith HSCs transducedwith SNAP-KAP1 vector, received an
intravenous injection of 800 pmol of TMR-Star per gram of BW, unlabeled
protein was blocked twice with 500 nmol of BG, and spleen was harvested
for analysis. All animal experiments were approved by the ‘‘Service de la
Consommation et des Affaires Ve´te´rinaires du canton de Vaud.’’
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